- Press Release
Jan 29, 2019: Birmingham, Ala., – PharmaPoint is proud to announce that Beth Israel Deaconess Medical Center (BIDMC) will use the XchangePoint platform to incorporate pharmacy expertise into the patient care process, proactively driving improved adherence for better outcomes and reduced risks.
The agreement will allow BIDMC to provide the most effective bedside, medication reconciliation, post follow-up and coordinated transition care programs for their patients. XchangePoint is designed to seamlessly integrate into the existing workflow, connecting the physician, pharmacy, health insurance companies and other clinical systems to ensure better patient outcomes and satisfaction.
“We are honored to have been chosen to partner alongside a team that is passionate about providing the best therapies utilizing the latest technologies,” says Mike Plaia, PharmaPoint CEO. “XchangePoint will apply healthcare analytics to provide strategic data that ultimately drives integrated process improvement capabilities into the overall ambulatory pharmacy program.”
PharmaPoint is an innovative, technology-enabled pharmacy management and software company. Through the management of outpatient retail pharmacies for hospitals, health systems and physician groups, our commitment to completing the care continuum results in improved patient health and satisfaction, reduced healthcare costs, and provides clients with a source of ancillary income. Additionally, XchangePoint, our proprietary integrated workflow management system supporting medication management across care transitions, is designed for pharmacy and care team members to drive medication optimization for at-risk patients in the acute, post-acute and ambulatory care settings. PharmaPoint has been recognized as one of the most innovative, inspiring and fastest growing private companies for six consecutive years (2013-2018) by Inc. Magazine. Headquartered in Birmingham, Ala., we are currently managing pharmacies across the United States. For more information about our company, please visit www.pharmapoint.com.